EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Acute treatment residual depression symptoms and functional impairment among depressive patients of different age groups and education levels in China: A prospective, multicenter, randomized study

Si Zu, Dong Wang, Jiexin Fang, Le Xiao, Xuequan Zhu, Wenyuan Wu, Xiufeng Lin, Gang Wang iD, Yongdong Hu

Brain and Behavior · 2024

DOI: 10.1002/brb3.70024 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Brain and Behavior, 2024. Verfasst von Si Zu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Major Depressive Disorder, Educational Status. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

A prospective, multicenter, randomized study evaluated the efficacy of major depressive disorder (MDD) patients after 2–3 months of acute treatment based on the dual factors of education and age.

Methods

This study classified the included patients into four groups using two classification parameters: age (≤45 years, vs. >45 years) and education years (≤12 vs. >12). We analyzed age, gender, marital status, personal income, depression onset history, medication use, and follow‐up across various groups. We evaluated residual somatic symptoms and social functioning in depression patients was conducted using the 16‐item Quick Inventory of Depressive Symptomatology Self‐report (QIDS‐SR16), the Patient Health Questionnaire‐15 (PHQ15), and the Sheehan Disability Scale (SDS).

Results

In China, 16 hospitals, 553 depression patients, and 428 fulfilled the inclusion criteria. Baseline patient data revealed significant differences among the different age groups in gender, marital status, income, first onset age, physical illness, combination of antipsychotics, and benzodiazepines use (all p < .05). Statistically significant differences were observed in overall comparisons among the four groups, encompassing the QIDS‐SR16 score, PHQ15 score, and various SDS parameters (all p < .05). However, no statistically significant differences (all p > .05) were found in residual somatic symptoms and social functioning parameters between different education levels (≤12 years vs. >12 years) at baseline, 3 months, and 6 months, based on total scores on the scale. Repeated measures mixed model indicates that the QIDS‐SR16 assessment indicates statistical differences among various marital statuses, income levels, medical histories, and antipsychotic medication use ( p < .05). Furthermore, PHQ‐15 and SDS assessments reveal statistical differences between single and married/cohabiting statuses, physical comorbidities, 3 and 6 months follow‐ups compared to baseline ( p < .05).

Conclusion

This study indicates that compared to depressive patients >45 years old, those ≤45 years old often exhibit more residual depression, somatic symptoms, and severe social functional impairment; patients' education levels less influence this trend.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderEducational StatusHumansMaleFemaleMiddle AgedAdultChinaProspective StudiesAge FactorsAntidepressive AgentsAgedYoung AdultTreatment Outcome

Stichwörter der Autor:innen

agedepressioneducationfollow‐upresidual symptom

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Department of Psychiatry, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • Department of Psychiatry, Tongji Hospital of Tongji University, Shanghai, China.
  • School of Information, Renmin University Beijing, China Research Institute, Kunlun Digital Technology, Co, Ltd. Beijing, China, Beijing, China.
  • Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.

ORCID-Profile: Gang Wang

Zitieren

APA

Zu, S., Wang, D., Fang, J., Xiao, L., Zhu, X., Wu, W., Lin, X., Wang, G., & Hu, Y. (2024). Acute treatment residual depression symptoms and functional impairment among depressive patients of different age groups and education levels in China: A prospective, multicenter, randomized study. Brain and Behavior. https://doi.org/10.1002/brb3.70024

Vancouver

Zu S, Wang D, Fang J, Xiao L, Zhu X, Wu W, et al. Acute treatment residual depression symptoms and functional impairment among depressive patients of different age groups and education levels in China: A prospective, multicenter, randomized study. Brain and Behavior. 2024. doi:10.1002/brb3.70024

BibTeX
@article{Zu2024,
  author = {Zu, Si and Wang, Dong and Fang, Jiexin and Xiao, Le and Zhu, Xuequan and Wu, Wenyuan and Lin, Xiufeng and Wang, Gang and Hu, Yongdong},
  title = {Acute treatment residual depression symptoms and functional impairment among depressive patients of different age groups and education levels in China: A prospective, multicenter, randomized study},
  journal = {Brain and Behavior},
  year = {2024},
  doi = {10.1002/brb3.70024}
}
Kostenlos starten →